Platelet Inhibition in Patients With Systolic Heart Failure
Status:
Completed
Trial end date:
2015-12-28
Target enrollment:
Participant gender:
Summary
The investigators aim to determine if patients with systolic heart failure treated with
prasugrel achieve greater platelet inhibition compared to those treated with clopidogrel.
Phase:
Phase 4
Details
Lead Sponsor:
University of Nebraska
Collaborators:
Daiichi Sankyo Inc. Daiichi Sankyo, Inc. Eli Lilly and Company